Toric IOL improves patient quality of life

Article

Implantation of a toric IOL results in improved patient quality of life and better visual, refractive and aberrometric results, states a new investigation.

Implantation of a toric IOL results in improved patient quality of life and better visual, refractive and aberrometric results, states a new investigation.

A team headed by Dr R. Mencucci, Department of Specialised Surgical Sciences–Eye Clinic, University of Florence, Florence, Italy, assessed three groups of subjects who underwent unilateral cataract surgery with IOL implantation.

The first group consisted of 40 patients with corneal astigmatism greater than 1.5 D implanted with an Acysof toric SN60TT IOL. Group two included 40 astigmatic patients implanted with the SN60AT IOL and group three included 40 patients with an astigmatism of less than 1.00 D implanted with an SB60AT IOL.

The outcome measures were uncorrected distance visual acuity (UDVA), refraction, lower order astigmatism, Strehl ratio and the modulation transfer function area ratio assessed over a three-month follow-up period. The group used a standardised quality of life test to assess both astigmatic groups three months postoperatively.

Postoperative UDVA and aberrometric values were significantly better in the toric and control group, compared with the SN60AT group. The mean postoperative spherical equivalent was significantly lower in the toric and control groups, compared to the SN60AT group.

Overall, the toric lens resulted in a better postoperative quality of life compared to the astigmatic SN60AT lens in astigmatic patients.

Please visit the British Journal of Ophthalmology to read the abstract.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
© 2025 MJH Life Sciences

All rights reserved.